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Abstract
“Awake craniotomy” is a technique used in neurosurgical procedures, commonly performed to remove a tumor or an epileptogenic
focus while the patient is awake. There has been an increasing trend towards performing this type of procedure because of its ad-
vantages; above all, the ability to map the eloquent cortex to reduce post-surgical neurological sequel. The aim of this article is to
introduce 8 cases of awake craniotomies, performed in Loghman-e-Hakim hospital in Tehran, Iran. Patients were selected according
to our specific criteria. Oral clonidine (4 µg/kg), dexamethason (8 mg/IV), midazolam (0.03 mg/kg/IV), and sufentanil (3 µg/kg/IV)
were used as premedication. Patients underwent cerebral state monitoring and other monitoring modalities during the procedure.
A laryngeal mask was used during the asleep phase of the anesthesia. General anesthesia was induced using propofol and lidocaine.
Local anesthesia was provided with bupivacaine in the incision and pin insertion sites. Anesthesia was maintained using propofol
and remifentanil infusion. A total of 8 patients underwent the procedure. No significant complications, including hemodynamic
instability, depressed respiration, the need to put the patient to sleep before mapping or tumor resection, intraoperative seizures,
aspiration, and brain edema were observed in any of our patients. In conclusion, we believe that a modified asleep-awake-awake
technique instead of the asleep-awake-asleep technique may provide less complications and less need to manage the patients’ air-
way.
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1. Introduction
Awake craniotomy has been used in various neurosur-
gical procedures, including seizure surgery and tumor re-
section in eloquent regions. The purpose of this procedure
is to provide intraoperative brain mapping of function-
ally important areas of the brain, namely the motor, sen-
sory, and speech cortices, to minimize the risk of damag-
ing these areas and thus decreasing neurological deficits
and also decreasing intensive care time and hospital stay
(1-10).
Different anesthetic methods have been used for this
type of procedure (1, 5, 11-19). The asleep-awake-asleep
method is one of the most widely used techniques (5, 20). It
comprises 3 phases. In the first phase, the patient’s airway
is usually maintained using a laryngeal mask or a tracheal
tube, local anesthesia is provided to the scalp and general
anesthesia is initiated after which the craniotomy is per-
formed. During the second phase the patient is awakened,
the eloquent cortex is mapped and the tumor/lesion is re-
sected. In the third phase, the patient is put to sleep again,
and the cranium is closed.
We report 8 successful cases of awake craniotomies
since 2008; the earliest to be done in Iran (2). The patients
were admitted to Loghman-e-Hakim hospital in Tehran,
Iran. Our approach consisted of a modification, which kept
the patients awake in the third stage instead of putting
them back to sleep.
The goal of the anesthesiologist is to initiate and main-
tain an adequate level of sedation and analgesia during the
procedure and to allow the patient to be able to cooperate
with the surgeon while mapping the cortex. It is also criti-
cal to manage the airway properly and to monitor patient’s
hemodynamic status (13, 18, 21).
2. Methods
2.1. Technique
Each institution uses different criteria to select pa-
tients. The exclusion criteria used for selecting patients at
this institution are outlined in the Table 1 (3, 22).
All patients were interviewed prior to the operation.
The procedure was explained in detail to each patient and
their compliance was subjectively assessed by the corre-
sponding anesthesiologist and neurosurgeon. Most of the
selected patients had lesions in the frontal or parietal lobe,
which could be operated in supine position.
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Table 1. Exclusion Criteria
Exclusion Criteria





- Low occipital tumor (prone position)
- Significant dural involvement (painful)
- Inability to lie still for many hours
- Inexperienced surgeon
- Patients with mental retardation
- Younger children
- Very large tumors
- Difficult airway
- History of Gastro-esophageal reflux (regurgitation)
At our hospital, we used oral clonidine with a dose of 4
µg/kg thirty minutes before surgery, and midazolam with
a dose of 0.03 mg/kg and sufentanil of 0.3 µg/kg as pre-
medication. Intravenous dexamethasone (8 mg) started
soon after admission to the operating room in order to de-
crease the edema and inflammation of brain tissue and
to also decrease the likelihood of emesis during proce-
dure. All patients received an anticonvulsant (Phenytoin
750 mg/IV/infusion) for seizure prophylaxis and IV manni-
tol 0.25 g/Kg to decrease intracerebral pressure.
All patients were monitored for temperature, blood
pressure (using noninvasive blood pressure monitoring),
pulse rate, O2 saturation level (using pulse-oximetry), end-
tidal CO2, electrocardiography, cerebral state monitoring
(CSM), and urinary output. An arterial line was placed in all
patients after induction of anesthesia and blood pressure
was being monitored beat to beat.
General anesthesia was induced using 2 mg/kg propo-
fol and 1 mg/kg lidocaine. Airway was managed using a
properly sized laryngeal mask airway (LMA). We did not
perform nerve block for any of the patients but did provide
local anesthesia by injection of 0.5% bupivacaine, a long-
acting local anesthetic, in the incision and pin insertion
sites.
Anesthesia was maintained using a propofol infusion
at a rate of 100 - 300µg/kg/min and remifentanil at a rate of
0.1 µg/kg/min to keep the depth of anesthesia between 40
and 60 on the CSM scale. Tidal volume and respiratory rate
were set to keep the peak airway pressure below 15 cmH2O
and the end-tidal CO2 between 35 - 40 mmHg.
In order to awaken the patients, the propofol and
remifentanil infusions were discontinued followed by
waiting until the patients fully woke up, the CSM displayed
a depth of 94 or more, and spontaneous ventilation had a
regular pattern.
During mapping of the regions of the cortex, the med-
ical team talked to the patient continuously, asked ques-
tions and gave different orders (e.g. moving an extrem-
ity) to assess patient’s articulation, motor movements, and
muscle tone.
During closure of the dura and cranium, unlike the es-
tablished method of asleep-awake-asleep, we kept the pa-
tients awake. Since there was no dural involvement in our
cases and the tumors were mostly located in the frontal
and parietal lobes, dural closure was pain free. If the pa-
tients experienced pain during the skin closure, the sur-
geon administered a local anesthetic infiltration.
2.2. Patients
2.2.1. Case 1
A 38-year-old male patient, with a history of refractory
seizures since the age of 7, was presented to the neurol-
ogy department. The patient had simple focal seizures
with preceding aura which then proceeded to general
tonic-clonic seizures. The patient was on a regimen of
6 antiepileptic drugs. The seizures mostly occurred dur-
ing his sleep, although did increase in frequency since 6
months after which they occurred as many as 3 times a
day while the patient was awake. The corresponding cor-
tex was diagnosed by Magnetic Resonance Imaging (MRI),
which was shown to be adjacent to the motor cortex. He
underwent awake craniotomy with mapping and removal
of the pathologic tissue.
He was discharged 15 days after the procedure, and at
the time of writing this article, was on 2 antiepileptic drugs
and had no recurrence of seizures.
2.2.2. Case 2
A 34-year-old female patient with a history of general-
ized tonic-clonic seizures since 5 years ago was admitted to
the neurology department. The patient was being treated
with carbamazepine and her seizures were under control,
having simple partial seizures limited to the face. However,
the frequency of the seizures increased since last year and
did not respond to changes in medication.
On the computed tomography (CT) imaging per-
formed, a hypodense lesion in the right frontal area with
compression on the lateral ventricle, suggestive of oligo-
dendroglioma, was noted.
She tolerated awake craniotomy and the lesion was
completely excised with no collateral damage to eloquent
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cortices. Hereafter, she was discharged with a minimal
dose of anticonvulsants and is seizure free.
2.2.3. Case 3
The patient was a 23 year-old- male with a history of
tonic-clonic seizures since the age of 8. The patient had
been on different regimens of anticonvulsive drugs with
no significant improvement.
The MRI showed a lesion in the left frontal (premotor)
cortex, suggestive of a dysembryoplastic neuroepithelial
tumor.
As the other cases, he successfully tolerated awake
craniotomy without experiencing any pain during the du-
ral and skin closures.
2.2.4. Case 4
A 39-year-old male with a history of sudden right-sided
hemiparesis, seizures, headaches, and vertigo one month
prior to the procedure, was admitted.
On the CT scan performed, an isodense lesion in left
frontoparietal area, suggestive of glioblastoma, was ob-
served.
2.2.5. Case 5
A 29-year-old woman with a previous history of two
surgeries for high-grade glial tumor (gliablastoma multi-
forme) in the past year was admitted with a diagnosis of
relapse of the tumor and symptoms.
On the CT scan, a residual tumor in the right parietal
lobe with a midline shift and pressure effect on the ventric-
ular system was visible.
She underwent awake craniotomy. The procedure did
not have any significant complications but due to nature
of the tumor, she unfortunately passed away later that year.
2.2.6. Case 6
A 38-year-old man with a history of recent-onset gen-
eralized tonic clonic seizures, dementia episodes, and
headaches was admitted.
The imaging revealed a tumor in the left occipitotem-
poral region, suggestive of an oligodendroglioma.
The patient underwent awake craniotomy and com-
plete tumor excision. He is now symptom-free without any
relapses and has an acceptable quality of life.
2.2.7. Case 7
A 32-year-old man suffering from left hemiparesis and
seizures, was admitted in 2010.
On the imaging, a cystic mass in the right parietal lobe
with T1 and T2 enhancement, suggestive of a cavernous he-
mangioma, was found.
After the surgery, he received sodium valproate for
three years as seizure prophylaxis. He had no episodes of
seizures after the procedure, and all medications were dis-
continued after three years. The hemiparesis was consid-
erably resolved and he was able to perform daily activities
without any difficulty.
2.2.8. Case 8
A 19-year-old woman, who had been experiencing
seizures since she was 4 months old as well as having a
transient right upper limb paralysis, was admitted. She
had been under medical treatment since the start of her
seizures, however, with limited success.
On the CT scan there was a huge low attenuation area
in left frontal lobe without any mass effect or shift in brain
tissue. The MRI was suggestive of encephalomalacia. She
also underwent uneventful awake craniotomy, resulting in
resolution of the paralysis and seizures and no relapse of
symptoms (Table 2).
Table 2. Brief Presentation of Cases
























































None of our patients experienced any significant com-
plications such as hemodynamic instability, depressed res-
piration, the need to put the patient to sleep before map-
ping or tumor resection was completed, intraoperative
seizures, aspiration, and brain edema.
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The awake craniotomy is done mainly in supine po-
sition and involves manipulation of the frontal and pari-
etal lobes, which therefore, causes the dural closure to be
less painful in the aforementioned areas in comparison to
basal parts of the brain. None of our patients experienced
pain during closure of the dura.
Since excision of the pathologic area was done under
close monitoring of the adjacent cortices, the cortical dam-
age was avoided and patient motor abilities remained in-
tact whilst the lesion excision was completed. In all pa-
tients the tumor/lesion was entirely resected and postop-
erative images were acceptable. The patients were dis-
charged in a good general state after the operation.
The patients were awake during the last stage of
surgery, which caused a fast-track transfer of patients to
the intensive care and a rapid reanimation of patients,
which then again contributed to the prompt discharge
and minimal postoperative complications.
4. Discussion
The main purpose of using awake craniotomy is to pro-
vide a more accurate manner with which the procedure of
resecting the area of interest in the brain is done, whether
it is a tumor, or seizure focus. As for any type of procedure,
it has both advantages and disadvantages.
The most prominent advantage, as said, is the ability
to localize the area of interest, sparing the innocent un-
involved tissue; most importantly the motor and speech
cortices. Other proposed advantages described, are a de-
crease in postoperative nausea and vomiting and the need
for medication to control pain (23), a shorter hospital stay,
less need for intensive care and fewer complications (1).
As described earlier, different methods for awake cran-
iotomy surgeries have been in use, and to date there is
no consensus on which method is superior. The three
phases of the asleep-awake-asleep technique and awake
craniotomy using local anesthesia and block of the sen-
sory nerve supply to scalp, are the two main methods for
awake craniotomy. The method we employed is a modifica-
tion of the asleep-awake-asleep technique, in which the ap-
proach is changed to asleep-awake-awake. Because of the
short half life of remifentanil, the combination of remifen-
tanil and propofol provides convenient anesthesia with ad-
equate control on the depth of anesthesia and a relatively
rapid recovery after the infusion is discontinued. Several
studies have compared different combinations of anes-
thetic techniques, including a mixture of volatile agents,
a mixture of a volatile agent and an IV agent, and a mix-
ture of two IV agents. In this regard, we only used intra-
venous anesthesia and avoided the inhalational anesthet-
ics to avoid potential effects of volatiles on brain relaxation
and nausea. Some have proposed more complications in
a certain group (for example, increased hypotension with
the use of sevoflurane (24)), while others have proposed
no significant superiority for one over another (25). Re-
cently, there is a tendency towards the short acting medica-
tions, which have less respiratory depressant effects, such
as dexmedetomidine, which is an alpha-2 agonist with de-
sired effects on hemodynamic indices and has shown to
decrease bleeding in some neurosurgical and skull base
surgeries (26). However, there are not enough prospective,
controlled studies regarding this manner and a universal
guideline cannot yet be introduced. Thus further research
should be carried out.
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